Data / Form D filings / CURAXIS PHARMACEUTICAL Corp
CURAXIS PHARMACEUTICAL Corp: Form D filing
CURAXIS PHARMACEUTICAL Corp, a pharmaceuticals company in Alpharetta, filed a Form D with the SEC in 2010. The latest, on February 18, 2010, reports $1.5 million sold of a $1.5 million offering to 72 investors.
Find out what CURAXIS PHARMACEUTICAL Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12600 DEERFIELD PARKWAY, SUITE 100, Alpharetta, 30004
- Phone
- (678) 566-3750
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1170723
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 18, 2010 | New notice | $1,526,000 | $1,526,000 | $0 | 72 | Feb 5, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Patrick S Smith | Executive Officer, Director | |
| Sheldon L Goldberg | Director | |
| Ronald Edward Pompeo | Director | |
| David J Corcoran | Executive Officer, Director | |
| William Edward McConville | Director | |
| Judy J Geaslen | Executive Officer |
Every Form D from the week of Feb 15, 2010 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what CURAXIS PHARMACEUTICAL Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.